Ceros Capital Markets - Institutional Quality Deals for Investors

Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound | MedTech Dive

Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs, industry observers say.

CEROS

Ceros predicts a rebound in strategic investments and IPOs in early 2023

(BioWorld) ...Goldwasser expects “we’re going to see a lot of transactions out of big strategics” and a rally in the equity market in the first half of 2023...

CEROS

Ceros Financial Services Arranges $7.5 Million Financing for Wesper

Ceros Financial Services announced that Ceros Capital Markets, its investment banking division, has completed a $7.5 million Series A round for Wesper, which has developed the first clinical-grade FDA cleared platform to bring the full cycle of sleep therapy to home users.

CEROS

Medtech prognosis remains healthy despite IPO slowdown

(AlternativesWatch) There has been a sharp decline in the medical technology IPO market this year -- and yet, investors seem as bullish as ever on gains in the space.

CEROS

ProMIS Neurosciences Announces Closing of US $7.4 Million Private Placement

ProMIS Neurosciences Inc. (Nasdaq: PMN) (TSX: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic misfolded proteins implicated in the development of...

CEROS

Exec Chat: "Wow Factor' Is Important in Medtech Investment, But It's Not Everything Says Ceros CEO

'There is a Revolution In Medtech And Money On the Sidelines, 'Ceros' Mark Goldwasser told Medtech Insight in an interview

CEROS

Ceros Financial Services Arranges $15 Million Financing For GT Metabolic Solutions

Ceros Financial Services announced that Ceros Capital Markets, its investment banking division, has completed an approximately $15 million Series A round for GT Metabolic Solutions, which has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery

MOMENTIS SURGICAL

Memic Announces Completion of First Patient Cases Using Hominis® Surgical System in Laparoscopic-Assisted Transvaginal Benign Gynecological Procedures

Patient procedures performed at HCA Florida Kendall Hospital and The Women's Hospital at Jackson Memorial with first and only FDA-authorized surgical robot with humanoid-shaped arms

CORDIO MEDICAL

Cordio Medical raises $18 million to leverage speech processing to monitor heart failure

The Israeli startup’s technologies are based on true speech signal processing technology, unique to each patient, augmented with machine learning capabilities

CEROS

Three Key Considerations To Secure Funding

There is capital sitting on the sidelines, but founders and CEOs should realize that investors are digging into their due diligence. The “wow” factor and potential size of the medtech market matter much less now than solid fundamentals.

DERMASENSOR

DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event

DermaSensor Inc. — the creator of a handheld, point-and-click device to quickly assess skin lesions for cancer risk — is the winner of the MedTech Innovator Mid-Stage Companies Pitch Event.

DERMASENSOR

DermaSensor raises $10M, completes pivotal FDA studies for its skin cancer detection device

(RefreshMiami) Today, DermaSensor is announcing that it has closed a $10 million round of financing, led by existing investors including Ceros Capital Markets.

CEROS

As Markets Reel, Startups Hope for ‘Flat’ Rounds

(WSJ) The froth of past valuations has waned. If a startup manages to get the same per-share price of its previous funding—a flat round—it’s a win. ‘Flat is the new up,’ says one startup CEO

PRISTINE SURGICAL

Ceros Financial Services Arranges $15 Million Financing for Pristine Surgical

Ceros, focused on early-stage medtech, completes placement for Single-use visualization platform

AQUYRE BIOSCIENCES

Ceros Financial Services Arranges $17.14 Million Financing of Aquyre Biosciences

Ceros focuses on investment in emerging medical technology companies.

CEROS

Healthtech to Benefit from Changed Consumer Behavior

Ceros Financial Services CEO Mark Goldwasser is banking on new health behaviors to drive healthtech in 2022.

CEROS

Why Ceros Focuses on Funding Medical Technology Start-ups

(InfoMedTechNews) With about $117 million in transactions by the end of 2021, Ceros Financial Services is building an investment banking platform focused on fundraising for early-stage medical technology and medical device companies.

CEROS

ProMIS Neurosciences Closes Upsized US$20,125,000 Public Offering

(Yahoo Finance) ...and Ceros Financial Services, Inc. acted as the exclusive sub-agent for the sale of Units in certain jurisdictions....

MOMENTIS SURGICAL

Robotics Firm Memic Is in Talks to Go Public Via SPAC

(Bloomberg) Memic Innovative Surgery, a medical-device company that specializes in robot-assisted surgery, is in talks to go public through a merger with MedTech Acquisition Corp., a blank-check firm, according to people with knowledge of the matter.

CEROS

Maurice R. Ferré’s Firm Making ‘Humanoid’-like Surgery Robots Acquired for $1B value

(Miami Herald) Dr. Maurice R. Ferré has helped mint the third $1 billion company with the announcement Friday that Memic, a robotic surgery company that he chairs, has been acquired by...

CEROS

Startup Medical-Device Acquisitions Picked Up in First Half of Year

(Wallstreet Journal) Medical-technology companies are buying more startups as the industry recovers from disruptions to healthcare procedures triggered by the global pandemic last year....

DERMASENSOR

Dermasensor Raises $11.5 Million In Series A Round

(RefreshMiami) On the road to bringing its first device to market, DermaSensor, a Miami-based health-tech company designing tools to better equip primary care providers for skin cancer checks, today announced…

MOMENTIS SURGICAL

Memic Raises $96M for it’s Robot-assisted Surgery Platform

(TechCrunch) Memic, a startup developing a robotic-assisted surgical platform that recently received marketing authorization from the U.S. Food and Drug Administration, today announced that it has closed a $96 million Series D funding round.

CEROS

Latest New York transplant: $100 million in investments for South Florida medtech companies

(Miami Herald) Latest to join is Ceros Financial Services, a financial advisory group that is raising $100 million over the next 12 months to fund emerging medical technology companies in South Florida and beyond.

MOMENTIS SURGICAL

Memic, a Medical Device Company Chaired by Maurice R. Ferré, Raises $96 Million

(Refresh Miami) Memic Innovative Surgery, a medical device company, today announced it has closed a $96 million Series D financing round. The company, based in Tel Aviv and Fort Lauderdale, has another South Florida tie:

CEROS

Medtech Funder Ceros Moving to Miami, Aiming to invest $100M

(RefreshMiami) A medical device company based in Fort Lauderdale and Tel Aviv that is chaired by Miami serial entrepreneur Maurice R. Ferré, closed a $96 million Series D financing round.

Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound | MedTech Dive

Ceros predicts a rebound in strategic investments and IPOs in early 2023

Ceros Financial Services Arranges $7.5 Million Financing for Wesper

Medtech prognosis remains healthy despite IPO slowdown

ProMIS Neurosciences Announces Closing of US $7.4 Million Private Placement

Exec Chat: "Wow Factor' Is Important in Medtech Investment, But It's Not Everything Says Ceros CEO

Ceros Financial Services Arranges $15 Million Financing For GT Metabolic Solutions

Memic Announces Completion of First Patient Cases Using Hominis® Surgical System in Laparoscopic-Assisted Transvaginal Benign Gynecological Procedures

Cordio Medical raises $18 million to leverage speech processing to monitor heart failure

Three Key Considerations To Secure Funding

DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event

DermaSensor raises $10M, completes pivotal FDA studies for its skin cancer detection device

As Markets Reel, Startups Hope for ‘Flat’ Rounds

Ceros Financial Services Arranges $15 Million Financing for Pristine Surgical

Ceros Financial Services Arranges $17.14 Million Financing of Aquyre Biosciences

Healthtech to Benefit from Changed Consumer Behavior

Why Ceros Focuses on Funding Medical Technology Start-ups

ProMIS Neurosciences Closes Upsized US$20,125,000 Public Offering

Robotics Firm Memic Is in Talks to Go Public Via SPAC

Maurice R. Ferré’s Firm Making ‘Humanoid’-like Surgery Robots Acquired for $1B value

Startup Medical-Device Acquisitions Picked Up in First Half of Year

Dermasensor Raises $11.5 Million In Series A Round

Memic Raises $96M for it’s Robot-assisted Surgery Platform

Latest New York transplant: $100 million in investments for South Florida medtech companies

Memic, a Medical Device Company Chaired by Maurice R. Ferré, Raises $96 Million

Medtech Funder Ceros Moving to Miami, Aiming to invest $100M

Share